2010 Conference Day 2 (Confirmed to date)

Thursday 3 June 2010

07:30 Breakfast and Registration

Technology Convergence; drivers, enablers, barriers and challenges.

09:.00

This session will explore the business models surrounding convergence of technologies relating to therapeutics and diagnostics. Speakers will consider the drivers of convergence, possible barriers and how the pathways to convergence are likely to be managed towards the over-arching objective of routine application for patient benefit.

Chair

• Nigel Job, CEO, Remtec Search and Selection Ltd

Speakers

• Dr Stephen Little, Vice President, Personalised Healthcare Qiagen
• Crispin Simon, CEO, Biocompatibles
• Simon McGuire General Director, Phillips Respironics Respiratory Drug Delivery

 

10:30 Morning Refreshments

Drug Delivery

11:10

This session will examine future technology trends in drug delivery, looking at both formulation and devices for injected, inhaled and transdermal applications.

Chair

• Dr Iain Simpson, Head of Drug Delivery, Sagentia

Speaker

• Dr Ryan Donnelly, Senior Lecturer in Pharmaceutics, Queens University, Belfast
• Dr Jan Jezek, Chief Scientific Officer, Arecor Limited
• Nic Bowman Director Device Design and Development, Pfizer
• Philip Green Senior Director, Drug Delivery Devices, Merck & Co

12:30 LUNCH

12:30 Stratified Medicine Discussion Forum (working lunch in the James Watson Room)

This lunchtime round table session is an opportunity for those with an interest in stratified medicine to explore the economic value of business-to-business partnerships and deal structures. The relative contributions of the various stakeholders will be explored, along with how best to engage the regulators and payers with the agenda of stratified medicine.

14:00 Keynote Speaker Session

Professor Nina Fedoroff, Science and Technology Advisor to the U.S. Secretary of State, U.S. Department of State

And So To The Future…

14:30

Speakers will take a forwards look at a range of mechanisms underpinning new innovation and the development and adoption of new technologies, as well as likely global regulatory and funding structures.

Chair

• Mr Ted Agne, President, Communications Strategy Group

Speakers

• Dr Thomas Okarma, President & CEO, Geron Corporation
• Dr Jackie Hunter, Senior Vice President, GlaxoSmithKline
• Dr Louise Wood, Head of Innovation and Industry R & D Relations, Department of Health
• Dr Guy Brown, Senior Lecturer in the Department of Biochemistry, University of Cambridge

16:30 Networking Drinks Reception & Canapés in the Orchard

16:30 Sequencing Tours start